Thursday, December 14, 2017 2:44:40 PM
Until then they are alive and breathing and can turn things around any quarter.
Sandusky is open and making money.
Share price dropping doesn't prove the business fundamentals have changed at all.
There are delays with new location openings. But overall still making revenue.
Business growth doesn't happen overnight.
Being patient sucks. But that's the price of long term investing.
.005 buys would seem very smart if next quarter report numbers are even bigger.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM